Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Immatics Biotechnologies Granted U.S. Patent #11685769: Peptides for use in immunotherapy against cancers

Author: Charles Gross | June 27, 2023 05:39am
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11685769

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11685769

Posted In: IMTX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist